Dimerix Limited (ASX:DXB)
0.405
-0.005 (-1.22%)
At close: Mar 6, 2026
Dimerix Market Cap
Dimerix has a market cap or net worth of 243.16 million as of March 6, 2026. Its market cap has decreased by -8.36% in one year.
Market Cap
243.16M
Enterprise Value
204.71M
Revenue
7.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
Market Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 243.16M, an increase of 1,737.06%. That is a compound annual growth rate of 31.35%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 240.11M |
| Tetratherix | 196.97M |
| Starpharma Holdings | 170.07M |
| Actinogen Medical | 150.18M |
| Recce Pharmaceuticals | 133.02M |
| Racura Oncology | 446.99M |
| Botanix Pharmaceuticals | 126.43M |
| Island Pharmaceuticals | 123.80M |